Srpski | Русский | Deutsch | Nederlands
Dysport at a glance
- What it is: a prescription medicine with botulinum toxin type A (abobotulinumtoxinA) that softens expression lines
- Studied for: frown lines between the brows, the „angry“ lines that show when you frown
- What to expect: in studies, first changes appeared within a few days, and for many people the effect lasted several months, with individual differences
- Who it is for: adults who want softer frown lines; the studies were done in adults aged 19 to 75
- Good to know: units are specific to each product: Dysport units cannot be converted into units of other botulinum toxins
On this page:
What is Dysport?
Frown lines between the brows often make you look tired or stern when you feel neither. Dysport is a prescription medicine with botulinum toxin type A that relaxes the muscles that create them, so your face looks more rested and approachable.
Its active substance is abobotulinumtoxinA. Every botulinum toxin product has its own units and its own prescribing information, so at the consultation it matters to know exactly which product is used.
What Dysport is approved for and what was studied
In studies, Dysport was tested on frown lines between the brows (glabellar lines), which come from the muscles that pull the brows down and together. If other areas bother you too, we choose a plan together at the consultation that makes sense for your face.
Serbia: the current summary of product characteristics for Dysport 500 units (ALIMS) lists therapeutic indications only: focal spasticity of the upper and lower limbs in adults, dynamic equinus foot deformity and upper-limb spasticity in children with cerebral palsy aged two and over, spasmodic torticollis, blepharospasm, hemifacial spasm and persistent severe primary axillary hyperhidrosis in adults. Frown lines between the brows are not listed in that document.
USA: the US label for Dysport lists, besides cervical dystonia and spasticity, the temporary improvement of moderate to severe frown lines between the brows (glabellar lines) in adults under 65.
This compares two documents. It is not a list of everything Dysport can or may be used for anywhere in the world. Other products and other countries can differ. If any use interests you, the doctor will explain at the consultation what it is based on.
What the research shows
In placebo-controlled studies in adults with moderate to severe frown lines between the brows, Dysport made the lines visibly softer. In one larger study (399 adults), 80% of those who received 50 units showed clear improvement at week 4 (at least two grades, to none or mild lines) by both the doctor’s and their own assessment, compared with 2.6% on placebo. In that study, more than half of participants still showed improvement at week 24.
The studies measure lines at full frown, and results differ from person to person.
What the treatment is like
Treatment starts with a consultation: we look at how your face moves, your brow position and what you want to change. Dysport is injected with a fine needle into the muscles between the brows; in the studies the dose was given at five points, and your own pattern and amount are adapted to your anatomy. The injections take a few minutes. Preparation and aftercare are in our guide before and after botox.
In the studies, first changes showed within a few days, and the full picture takes a little longer. The doctor decides the interval to the next treatment.
Who it is for
Dysport is a topic for adults who are bothered by frown lines between the brows and want a softer, more rested look without surgery. At the consultation the doctor assesses your goals and recommends what suits you.
Safety: what you should know
The most common reactions are local or mild: pain or a reaction at the injection site, headache, eyelid swelling and cold-like symptoms. A drooping eyelid occurred in about 2% of treated people in the studies and is usually temporary. Dry eye or an allergic reaction can occur rarely. Very rarely the effect of the toxin can spread beyond the injection site. If you have trouble swallowing, speaking or breathing after treatment, get medical help immediately.
Treatment is not done with hypersensitivity to any ingredient, with an infection at the injection site, or during pregnancy and breastfeeding. If you have a confirmed allergy to cow’s milk protein (this is not the same as lactose intolerance), tell your doctor: the product may contain trace amounts of these proteins. Special care is needed with nerve and muscle diseases such as myasthenia gravis or Eaton-Lambert syndrome. Tell your doctor which medicines you take and whether you have had botulinum toxin before.
A dose of one product cannot be carried over to another. If you have had another botulinum toxin before, bring the product name to the consultation.
Other options for the same goal
See also: botox, Vistabel, botulinum toxin brands and Bocouture or Botox.
Frequently asked questions
Is Dysport the same as Botox?
No. They are two different botulinum toxin type A products, each with its own prescribing information and its own units. The number of units of one product cannot be compared with the same number of another.
When will I see results?
In studies, first changes showed within a few days. The full effect is assessed after a few weeks.
How long does it last?
In studies, the improvement lasted several months for many people, with individual differences. The doctor decides the interval to the next treatment.
Which lines was Dysport studied for?
Frown lines between the brows in adults with moderate to severe lines at full frown.
Can I ask for the same number of units as with another product?
No. Dysport units cannot simply be equated with units of other products; the doctor plans the dose for the specific product and your face.
References
- Joseph J, Moradi A, Lorenc ZP, Coleman K, Ablon G, Kaufman-Janette J, Cox SE, Campbell A, Dayan S, Berg AK, Munavalli G. AbobotulinumtoxinA for the treatment of moderate-to-severe glabellar lines: a randomized, dose-escalating, double-blind study. J Drugs Dermatol. 2021;20(9):980-987. PubMed 34491016
- Brandt F, Swanson N, Baumann L, Huber B. Randomized, placebo-controlled study of a new botulinum toxin type A for treatment of glabellar lines. Dermatol Surg. 2009;35(12):1893-1901. doi:10.1111/j.1524-4725.2009.01235.x
- DYSPORT (abobotulinumtoxinA) prescribing information, section 1.2, 2.4, 5, 6 and 14. U.S. Food and Drug Administration. accessdata.fda.gov
- Dysport 500 jedinica, prašak za rastvor za injekciju: sažetak karakteristika leka (SmPC), odeljak 4.1. ALIMS, Srbija (provereno 27.10.2026). alims.gov.rs
Read more
Book a consultation: +381 66 378 372
Price list See our treatment prices Call us Book your treatment
